

Sequella, Inc. Information
Contact top employees from
Sequella, Inc.
Summary
Sequella, Inc. is a private company that has been in the industry for 28 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Co-Founder & CEO is occupied by Carol A. Nacy. Its headquarters is located at Rockville, Maryland, USA. The number of employees ranges from 25 to 100. The annual revenue of Sequella, Inc. varies between 5.0M and 25M. Total funding of the company - $11.9M. To connect with Sequella, Inc. employee register on SignalHire.
Industries
Biotechnology
Employees Size
1-10 employees
SIC Code
2836
DMA Code
Washington Metropolitan Area
Founded
1997
Estimated Annual Revenue
$5.0M - 25M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
2009 | Privately Held | 1 - 25 | 5M | $43M | |
1996 | Public Company | 100 - 250 | 250.5M | $293.1M | |
2000 | Privately Held | 25 - 100 | 4.1M | $3M | |
2005 | Public Company | 250 - 500 | 41.3M | $428.7M | |
2000 | Privately Held | 500 - 1.0K | 21.4M | $1.5B | |
1998 | Public Company | 100 - 250 | 413M | $652.8M | |
2012 | - | 25 - 100 | 10.3M | $23.3M | |
- | Privately Held | 100 - 250 | 37.3M | $0 | |
2003 | - | 10-50 | - | $- | |
2009 | - | 100-200 | - | $- | |
- | - | 1-10 | - | $- |
Employees Turnover 2 quarter 2025
Length of Employment
Employee tenure at Sequella, Inc. shows a diverse range of experience levels:
5% for 1–2 years5% for 3–4 years14% for 8–10 years77% have over 11 years of service at Sequella, Inc.Contact top employees from
Sequella, Inc.
Mark Rampy
Chief Business Officer
Carol Nacy
CEO
Lisa Beth Ferstenberg
Medical Director
Boris Nikonenko
Senior Scientist